Levofloxacin induced polymorphic ventricular tachycardia with normal QT interval

PACE - Pacing and Clinical Electrophysiology

Volumn 24, Issue 5, 2001, Pages 895-897

  Paltoo, Brendon ^b   O'Donoghue, Susan ^b   Mousavi, Morteza S ^a  

^a Potomac Hospital   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

Levofloxacin; Polymorphic ventricular tachycardia; QT interval

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; LEVOFLOXACIN; PSYCHOTROPIC AGENT;

ADULT; ARTICLE; CASE REPORT; CLINICAL TRIAL; ELECTROLYTE DISTURBANCE; FEMALE; HEART VENTRICLE TACHYCARDIA; HUMAN; LONG QT SYNDROME; QRS COMPLEX; QT INTERVAL; TORSADE DES POINTES; URINARY TRACT INFECTION;

EID: 2942597208     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2001.00895.x     Document Type: Article

References (5)

1. 1. Dupont H, Timsit JF, Souweine B, et al. Torsades de pointe probably related to sparfloxacin. Eur J Clin Microbiol Infect Dis 1996; 15:350-351.
2. 2. Kastor J. Arrythmias, W.B. Saunders, Philadelphia, 1994, p. 379.
3. 3. Physicians' Desk Reference, Montvale, NJ, Medical Economics, 2000, pp. 2161-2165.
4. 4. Chennareddy CB, Mohamed S, Karim MY, et al. Erythromycin-induced polymorphous ventricular tachycardia with normal QT interval. Am Heart J 1996; 132:691-694.
5. 5. Rubart M, Presslar ML, Pride HP, et al. Electrophysiological mechanisms in a canine model of erythromycin-associated long QT syndrome. Circulation 1993; 88:1832-1844.